,tiragolumab,carboplatin,,atezolizumab,etoposide,trastuzumab deruxtecan
roche,astrazeneca,daiichi sankyo
['sclc', 'bcsm', 'destiny,breast,4', 'skyscraper-02', 'skyscraper,2 ', 'breast', 'destiny-breast04', 'tiragolumab', 'atezo', 'enhertu']
live from the #asco22 congress floor! join us for part 2 of our asco snacks series. we review exciting data from destiny-breast04 (enhertu in her2-low) and skyscraper-02 (atezo + tiragolumab in es-sclc). apple: spotify: #bcsm
curious enthusiast